Adimmune Corporation
4142
Rank in Stocks
#16647
Adimmune Corporation, a Taiwanese pharmaceutical company, specializes in the... Adimmune Corporation, a Taiwanese pharmaceutical company, specializes in the production and distribution of human vaccines. Its comprehensive product portfolio includes a range of critical immunizations. Key offerings feature the quadrivalent influenza vaccine, AdimFlu-S, alongside trivalent influenza vaccines and the Influenza A (H1N1) Virus Monovalent Vaccine. The company also provides tetanus toxoid products, vital for post-injury tetanus prevention, and Japanese encephalitis vaccines. Furthermore, Adimmune supplies purified Tuberculin and extends its expertise through contract manufacturing services. Established in 1965, the company initially operated under the name Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. It subsequently rebranded as Adimmune Corporation in 2001 and maintains its headquarters in Taichung, Taiwan.
Share Price
$0.50997489
Last synced: 2026-11-13
Market Cap
$201.18M
Change (1 day)
0.40%
Change (1 year)
-27.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Adimmune Corporation (4142)
Category
Healthcare
EPS for Adimmune Corporation (4142)
EPS as of September 2026 TTM: $0.01
According to Adimmune Corporation's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for Adimmune Corporation from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -126.00% |
| 2025 | $-0.02 | 2.82% |
| 2024 | $-0.02 | -64.24% |
| 2023 | $-0.05 | -322.97% |
| 2022 | $0.02 | 516.67% |
| 2021 | 0.00 | -96.66% |
| 2020 | $0.11 | -519.84% |
| 2019 | $-0.03 | -70.01% |
| 2018 | $-0.09 | -17.20% |
| 2017 | $-0.10 | 39.30% |
| 2016 | $-0.07 | -20.62% |
| 2015 | $-0.09 | 2.74% |
| 2014 | $-0.09 | -11.98% |
| 2013 | $-0.10 | -6.92% |
| 2012 | $-0.11 | 23.42% |
| 2011 | $-0.09 | -376.38% |
| 2010 | $0.03 | -70.55% |
| 2009 | $0.11 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -17,215.38% |
US
|
|
| $15.66 | 301,053.85% |
US
|
|
| $-7.07 | -136,061.54% |
US
|
|
| $-5.29 | -101,830.77% |
AU
|
|
| $12.73 | 244,750.00% |
BE
|
Questions about Adimmune Corporation's earnings per share (EPS)
What is Adimmune Corporation's earnings per share (EPS)?
Adimmune Corporation's earnings per share (EPS) over the last twelve months is $0.01, as of Sep 2026.
What was Adimmune Corporation's earnings per share (EPS) in 2025?
In 2025, Adimmune Corporation's earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has Adimmune Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Adimmune Corporation's earnings per share (EPS) was highest in 2020 ($0.11) and lowest in 2023 ($-0.05).
How does Adimmune Corporation's earnings per share (EPS) compare with similar companies?
Adimmune Corporation's earnings per share (EPS) ($0.01) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.